A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women
Open Access
- 13 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 38 (1), 86-93
- https://doi.org/10.1093/ageing/afn227
Abstract
Background: a small number of reports exist on the cognitive effects of soy isoflavones, the findings from which are mixed. Isoflavone efficacy is dependent upon conversion of glycosides contained in soy foods and supplements to the biologically active aglycons. Of particular interest is the production of the metabolite, equol, which is dependent upon intestinal microflora and an integrous digestive system, both being altered by age and age-associated conditions. Unfortunately, few studies enrolled adults over the age of 70, and none included older men. Objective: we examined safety, feasibility and cognitive efficacy of soy isoflavone administration in older nondemented men and women (age 62–89 years). Design and Methods: in this randomised, placebo-controlled, double-blind pilot study, subjects ingested either 100 mg/day soy isoflavones (glycoside weight) or matching placebo tablets for 6 months. Results: active and placebo-treated subjects exhibited a comparable side-effect profile. Plasma levels of genistein and daidzein (P < 0.001), but not equol, increased with isoflavone administration. While similar at baseline, the two groups differed across 6 months of treatment on 8 of 11 cognitive tests administered. Isoflavone-treated subjects improved on tests of visual-spatial memory (P < 0.01) and construction (P = 0.01), verbal fluency (P < 0.01) and speeded dexterity (P = 0.04). Placebo-treated participants were faster than isoflavone-treated subjects on two tests of executive function (P < 0.05). Conclusions: these data suggest that administration of 100 mg/day of isoflavones was well tolerated. Plasma genistein and daidzein levels, but not equol, increased with isoflavone administration. Finally, data support the potential cognitive effects of soy isoflavones in older adults.This publication has 30 references indexed in Scilit:
- Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese womenMenopause, 2007
- Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal womenMenopause, 2007
- Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled studyFertility and Sterility, 2006
- Research opportunities for reducing the burden of menopause-related symptomsAmerican Journal Of Medicine, 2005
- Soy isoflavones and cognitive functionThe Journal of Nutritional Biochemistry, 2005
- Endocrine and Cognitive Effects of Short-Time Soybean Consumption in WomenGynecologic and Obstetric Investigation, 2005
- World Medical Association. World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human SubjectsJournal international de bioéthique et d'éthique des sciences, 2004
- Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) StudyMenopause, 2003
- Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonistThe EMBO Journal, 1999
- The Short Form of the Geriatric Depression Scale: A Comparison With the 30-Item FormJournal of Geriatric Psychiatry and Neurology, 1991